Caplight Logo









Idoven

Idoven

Private
MadridHealthcare & Life Scienceshttps://www.idoven.ai/

Last Round

Series A

Extension

Sep 5, 2023

Total Funding Raised

$24.51M

Company Overview

Idoven is a health technology company that provides an AI-powered platform for electrocardiogram (ECG) analysis to enable early detection and precision medicine for cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Clinical Trials, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AI ECG analysisECG analysisCardiology-as-a-Servicediagnostic AImedical AIECG interpretationcardiovascular diagnosiscardiac safetyhealthcare SaaSclinical trial analyticshardware-agnostic platformpredictive diagnosticsMedTech AItelecardiologyhealthcare APICE marked devicepreventative screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Idoven Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Idoven Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 5, 2023
GrantJul 31, 2023
Series AJun 21, 2022
GrantApr 30, 2022
SeedMay 26, 2021
Grant
May 26, 2021

Key People

Founding team and executive leadership

Manuel Marina Breysse

Co-Founder & CEO

Founding Team

Tomás Pérez

Chief Technology Officer

Executive Team

Idoven Investors

Notable investors and investment history

InvestorRounds
European Innovation CouncilGrant
European CommissionGrant
WayraSeed, Series A
EIT HealthGrant
NorthzoneSeries A, Series A Extension
Gasol16 VenturesSeries A Extension
Empresa Nacional de InnovaciónSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 5, 2023

    Led by Insight Partners and Northzone.

  • Jul 31, 2023

    $1.65M grant received from EIT Health.

Idoven Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Idoven Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Idoven's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range71
Year Founded2018
Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.